Recruiting NA INTERVENTIONAL 2-arm NCT04655885

Cardiac Output Optimization on Postoperative Complications in Major Hepatic Surgery (OPTILIVER)

Effect of an Individualized Protocol Based on Cardiac Output Optimization Guided by Dynamic Indices of Preload Responsiveness Monitoring on Postoperative Complications in Major Hepatic Surgery for Primary or Secondary Liver Cancer

Sponsor: Institut Paoli-Calmettes

Conditions Primary or Metastatic Hepatic Adenocarcinoma

Interventions Control arm Optimization of cardiac flow by base water-electrolyte supply

Updated 6 times since 2021 Last updated: Apr 8, 2024 Started: Feb 3, 2022 Primary completion: Mar 15, 2026 Completion: May 15, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04655885, this NA trial focuses on Primary or Metastatic Hepatic Adenocarcinoma and remains actively recruiting participants. Sponsored by Institut Paoli-Calmettes, it has been updated 6 times since 2022, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
May 2024 — Jul 2024 [monthly]

Recruiting NA
Apr 2022 — May 2024 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Feb 2022 — Apr 2022 [monthly]

Not Yet Recruiting NA

▶ Show 1 earlier version

Jan 2021 — Feb 2022 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Institut Paoli-Calmettes

Data source: Institut Paoli-Calmettes

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Marseille, France